Thomas Barba
Overview
Explore the profile of Thomas Barba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
561
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barba T, Robert M, Hot A
Rev Med Interne
. 2025 Feb;
PMID: 39984315
Artificial intelligence (AI) is experiencing considerable growth in medicine, driven by the explosion of available biomedical data and the emergence of new algorithmic architectures. Applications are rapidly multiplying, from diagnostic...
2.
Charmetant X, Rigault G, Chen C, Kaminski H, Visentin J, Taton B, et al.
Transpl Int
. 2025 Feb;
38:12859.
PMID: 39944220
The generation of donor-specific antibodies (DSA) requires that alloreactive B cells receive help from follicular helper T (T) cells. Recent works have suggested that γδ T cells could contribute to...
3.
Trefond L, Chasset F, Jachiet M, Livideanu C, Barba T, Faguer S, et al.
RMD Open
. 2025 Jan;
11(1.
PMID: 39756824
No abstract available.
4.
Sorin B, Papo M, Sinico R, Teixeira V, Venhoff N, Urban M, et al.
J Autoimmun
. 2024 Nov;
149:103338.
PMID: 39549485
Objectives: Current guidelines suggest treating poor-prognosis eosinophilic granulomatosis with polyangiitis (EGPA) with a combination of glucocorticoids (GCs) plus cyclophosphamide (CYC). However, there is little data to support the need for...
5.
Chauvelot L, Barba T, Saison C, Siska E, Kulifaj D, Bakker S, et al.
J Med Virol
. 2024 Jul;
96(7):e29806.
PMID: 39007420
Optimization of individual immunosuppression, which reduces the risks of both graft loss and patients' death, is considered the best approach to improve long-term outcomes of renal transplantation. Torque Teno Virus...
6.
Fauquier A, Barba T, Hot A, Seve P, Elbany S, Blanche P, et al.
Ocul Immunol Inflamm
. 2023 May;
32(4):402-406.
PMID: 37141529
Purpose: The study aims to determine the impact of initial management in Vogt-Koyanagi-Harada syndrome (VKHS). Methods: Patients diagnosed with a VKHS between January 2001 and December 2020 in two French...
7.
Billet A, Barba T, Coutant F, Fabien N, Perard L, Seve P, et al.
Biomedicines
. 2022 Dec;
10(12).
PMID: 36551932
Objective: Dermatomyositis associated with anti-MDA5 autoantibodies (DM-MDA5+) is a rare autoimmune disease usually characterized by skin involvement, often-severe lung involvement, and general features. Several reports of infections have been described,...
8.
Charmetant X, Chen C, Hamada S, Goncalves D, Saison C, Rabeyrin M, et al.
Sci Transl Med
. 2022 Sep;
14(663):eabg1046.
PMID: 36130013
The generation of antibodies against donor-specific major histocompatibility complex (MHC) antigens, a type of donor-specific antibodies (DSAs), after transplantation requires that recipient's allospecific B cells receive help from T cells....
9.
Bouchet A, Muller B, Olagne J, Barba T, Joly M, Obrecht A, et al.
Nephrol Dial Transplant
. 2022 Jun;
37(12):2555-2568.
PMID: 35675302
Background: The standard-of-care protocol, based on plasma exchanges, high-dose intravenous immunoglobulin and optimization of maintenance immunosuppression, can slow down the evolution of antibody-mediated rejection (AMR), but with high interindividual variability....
10.
Heiblig M, Ferrada M, Koster M, Barba T, Gerfaud-Valentin M, Mekinian A, et al.
Blood
. 2022 May;
140(8):927-931.
PMID: 35609174
No abstract available.